dabigatran has been researched along with Pregnancy in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Vauzelle, C | 1 |
| Barden, S; Campbell, T; Condliffe, R; Connolly, V; Davies, CWH; Donaldson, J; Everett, B; Free, C; Horner, D; Howard, LSGE; Hunter, L; Kaler, J; Nelson-Piercy, C; O-Dowd, E; Patel, R; Preston, W; Sheares, K | 1 |
| Arachchillage, DJ; Cohen, H | 1 |
| Aleksa, K; Bapat, P; Berger, H; Kedar, R; Koren, G; Lubetsky, A; Matlow, JN | 1 |
| Kadauke, S; Khor, B; Van Cott, EM | 1 |
| Condliffe, R; Elliot, CA; Hurdman, J; Kiely, DG; Maclean, RM; Quadery, R; Sabroe, I; van Veen, JJ | 1 |
| Budykina, TS; Khorikova, EN; Mikhailova, IS; Mravyan, SR; Popov, VV; Pronina, VP; Shuginin, IO; Stepanova, EA | 1 |
| G Andersson, N | 1 |
| Conard, J; Horellou, MH; Samama, MM | 1 |
| Dager, WE; Fanikos, J; Gulseth, MP; Nutescu, EA; Spinler, SA; Wittkowsky, AK | 1 |
| Haas, S; Kreutz, R; Llau, J; Norrving, B; Turpie, AG | 1 |
| Du, S; Giese, C; Harenberg, J; Krämer, R; Krämer, S; Schulze, A; Weiss, C | 1 |
4 review(s) available for dabigatran and Pregnancy
| Article | Year |
|---|---|
British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE).
Topics: Ambulatory Care; Anticoagulants; Dabigatran; Female; Hemorrhage; Humans; Length of Stay; Male; Neoplasms; Patient Discharge; Patient Selection; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Severity of Illness Index; Substance Abuse, Intravenous; Thiazoles | 2018 |
Use of new oral anticoagulants in antiphospholipid syndrome.
Topics: Administration, Oral; Adult; Animals; Anticoagulants; Antiphospholipid Syndrome; Benzimidazoles; beta-Alanine; Breast Feeding; Clinical Trials, Phase III as Topic; Contraindications; Dabigatran; Drug Monitoring; Female; Humans; Infant, Newborn; Maternal Exposure; Morpholines; Pregnancy; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Thiophenes | 2013 |
Dabigatran etexilate in clinical practice: confronting challenges to improve safety and effectiveness.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Dabigatran; Drug Approval; Drug Design; Female; Humans; Practice Guidelines as Topic; Pregnancy; Pyridines; Thrombin; Thrombosis; United States; United States Food and Drug Administration | 2011 |
Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitor.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Female; Humans; Male; Morpholines; Practice Guidelines as Topic; Pregnancy; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2012 |
8 other study(ies) available for dabigatran and Pregnancy
| Article | Year |
|---|---|
[Direct oral anticoagulants and pregnancy].
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Humans; Pregnancy; Stroke | 2021 |
Transfer of dabigatran and dabigatran etexilate mesylate across the dually perfused human placenta.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Contraindications; Dabigatran; Female; Fetus; Humans; In Vitro Techniques; Maternal-Fetal Exchange; Perfusion; Placenta; Pregnancy; Pregnancy Complications, Hematologic; Prodrugs; Pyridines | 2014 |
Activated protein C resistance testing for factor V Leiden.
Topics: Activated Protein C Resistance; Adult; Antithrombins; Arginine; Benzimidazoles; beta-Alanine; Biological Assay; Blood Coagulation Tests; Child; Dabigatran; Factor V; Factor Xa; False Positive Reactions; Female; Hirudins; Humans; Lupus Coagulation Inhibitor; Morpholines; Peptide Fragments; Pipecolic Acids; Pregnancy; Protein C; Recombinant Proteins; Rivaroxaban; Sulfonamides; Thiophenes; Warfarin | 2014 |
Management of acute pulmonary embolism.
Topics: Acute Disease; Age Factors; Ambulatory Care; Anticoagulants; Antithrombins; Comorbidity; Dabigatran; Disease Management; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hospitalization; Humans; Male; Neoplasms; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Cardiovascular; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thrombolytic Therapy; Tissue Plasminogen Activator; Vena Cava Filters; Warfarin | 2015 |
[INFECTIOUS ENDOCARDITIS IN PREGNANT WOMEN].
Topics: Adult; Anti-Bacterial Agents; Antithrombins; Dabigatran; Daptomycin; Echocardiography; Endocarditis, Bacterial; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Mitral Valve; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Tomography, X-Ray Computed; Treatment Outcome; Venous Thromboembolism | 2015 |
[Clear advice important when fertile women are prescribed NOAC].
Topics: Anticoagulants; Contraindications; Dabigatran; Female; Humans; Patient Education as Topic; Pregnancy; Rivaroxaban | 2016 |
[Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians].
Topics: Abnormalities, Drug-Induced; Adult; Anticoagulants; Benzimidazoles; Blood Loss, Surgical; Cesarean Section; Contraindications; Dabigatran; Europe; Evidence-Based Medicine; Female; Fetus; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; Morpholines; Polysaccharides; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Pyridines; Rivaroxaban; Societies, Medical; Thiophenes; Thrombophilia; United States; Uterine Hemorrhage; Venous Thromboembolism; Warfarin | 2009 |
Novel methods for assessing oral direct factor Xa and thrombin inhibitors: use of point-of-care testing and urine samples.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Chemistry Tests; Dabigatran; Factor Xa Inhibitors; Female; Humans; Male; Morpholines; Point-of-Care Systems; Pregnancy; Reproducibility of Results; Rivaroxaban; Thiophenes | 2013 |